Michael York - 27 Feb 2022 Form 4 Insider Report for Metacrine, Inc.

Role: Chief Business Officer
Signature: /s/ Michael York
Issuer symbol: N/A
Transactions as of: 27 Feb 2022
Net transactions value: $0
Form type: 4
Filing time: 01 Mar 2022, 15:55:17 UTC
Previous filing: 24 Feb 2022
Next filing: 27 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MTCR	Common Stock	Award	$0	+210,553		$0.000000	210,553	27 Feb 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MTCR	Stock option (right to buy)	Award	$0	+210,553		$0.000000	210,553	27 Feb 2022	Common Stock	210,553	$0.4700	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares of Common Stock issued to the Reporting Person pursuant to an award of restricted stock units. The award vests in full on February 27, 2023, subject to the Reporting Person's continued service to the Issuer.
F2	50% of the shares of Common Stock subject to the stock option shall vest and become exercisable on February 27, 2023, and the remaining shares shall vest and become exercisable in equal installments on the last day of each of the following 12 months until fully vested on February 27, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date.